May 12, 2020
by Andrii Buvailo
Interview
Personalized medicine has become a paradigm-shifting trend in healthcare - the hegemony of “one-size-fits-all” drugs is increasingly challenged by novel innovative …
May 1, 2020
by Andrii Buvailo
Interview
There is a great deal of hype and a lot of misconceptions among life science experts as to how AI …
March 23, 2020
by Rasim Shah
Biopharma insight
Moments of crisis always mean change. In these times, it’s tempting to reach for quotes from leaders who successfully navigated through turbulent …
March 20, 2020
by Nikos Tzagarakis
Biopharma insight
Tzager is an A.I. agent built for biomedicine research, drug discovery and personalized medicine, with the main features being Biochemical …
March 4, 2020
by Irina Bilous
Biopharma insight
Alongside the topic of gene editing technologies that keeps making headlines these days, there is also a wave of breakthroughs …
Feb. 19, 2020
by Irina Bilous
Biopharma insight
A transformative technology for gene editing - clustered regularly interspaced short palindromic repeats (CRISPR) -- has become ubiquitous, at least …
Feb. 17, 2020
by Rasim Shah
Biopharma insight
As we enter a new decade, our belief in the the impact of Artificial intelligence (AI) is only getting stronger. …
Feb. 9, 2020
by Irina Bilous
Biopharma insight
The number of immunotherapies in clinical trial rolls over 5000 now, and immunology has become a common approach in some …
Feb. 6, 2020
by Caroline Green
Biopharma insight
In a recent study published in Nature Communications, scientists from Cornell University made new findings in common and fatal gastric …
Feb. 4, 2020
by Peter Jarowski
Biopharma insight
Chemical Data Has Problems The state of data access, quality and dissemination in Chemistry is extremely poor - so poor …
Jan. 28, 2020
by Andrii Buvailo
Interview
Computer-aided drug design (CADD) is a central part of so-called “rational drug design”, pioneered in the last century by companies …
Jan. 2, 2020
by Andrii Buvailo
Biopharma insight
There is a plethora of analytics reports, including ones by Deloitte, DKV Global, and Ernst and Young, all pointing out …